The Patent Finder

Zhejiang Beta Pharma Inc.

Also on record
Records under this name other than patents Zhejiang Beta Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Zhejiang Beta Pharma Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,951,959Glucagon-Like PEPTIDE-1 Analogues and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,409,900Compound for increasing kinase active and application thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,742,138Compounds as hypoxia mimetics, and compositions and uses thereof
Formerly held
Lapsed on the fee record
Ended Jun 3, 2026 · USPTO record
Lapsed on the fee recordEnded Jun 3, 2026USPTO record
US 9,487,570Glucagon like peptide analogs, composition, and method of use
Formerly held
Lapsed on the fee record
Ended Nov 8, 2024 · USPTO record
Lapsed on the fee recordEnded Nov 8, 2024USPTO record
US 9,242,991Substituted fused heterocycles as c-Met tyrosine kinase inhibitors
Formerly held
Lapsed on the fee record
Ended Jan 26, 2024 · USPTO record
Lapsed on the fee recordEnded Jan 26, 2024USPTO record
US 8,822,482Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof
Formerly held
Lapsed on the fee record
Ended Sep 2, 2022 · USPTO record
Lapsed on the fee recordEnded Sep 2, 2022USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited